# Somatostatin Analogue SOM230 (Pasireotide) in Healthy Male Volunteers

> **NCT01128192** · PHASE2 · COMPLETED · sponsor: **Robert R. Henry, MD** · enrollment: 45 (actual)

## Conditions studied

- Hyperglycemia

## Interventions

- **DRUG:** pasireotide

## Key facts

- **NCT ID:** NCT01128192
- **Lead sponsor:** Robert R. Henry, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2014-12-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01128192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01128192, "Somatostatin Analogue SOM230 (Pasireotide) in Healthy Male Volunteers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01128192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*